San Mateo, CA, United States of America

Jeffrey Charles Lotz

This inventor holds 26 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Magnetic Resonance Spectroscopy. Top assignees: University of California, Nocimed, Inc., Aclarion, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Charles Lotz. Retrieved from https://idiyas.com/inventor/jeffrey-charles-lotz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 73.1

 

 

Average Co-Inventor Count = 3.5

ph-index = 15

Forward Citations = 1,097(Granted Patents)


Location History:

  • San Mateo, CA (US) (2007 - 2021)
  • Oakland, CA (US) (2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nuclear Magnetic Resonance
Pain Diagnosis
Thermal Treatment
Chemical Denervation
Intervertebral Discs
Directional Therapy
Biomarkers
Microwave Sources
Musculoskeletal Tissue
Ultrasound Therapy
Implantable Devices
Degenerative Properties
26 patents (USPTO):Explore Patents

Title: Jeffrey Charles Lotz: Innovator in Magnetic Resonance Spectroscopy

Introduction

Jeffrey Charles Lotz is an esteemed inventor based in San Mateo, California, renowned for his significant contributions to the field of medical diagnostics through magnetic resonance spectroscopy. With a total of 25 patents to his name, he has dedicated his career to innovation in diagnosing conditions associated with pain and infection.

Latest Patents

One of Lotz's latest inventions is a magnetic resonance spectroscopy (MRS) system and method for diagnosing pain or infections associated with propionic acid. This revolutionary approach offers a means to measure spectral information relevant to propionic acid, either independently or alongside other chemicals, to better diagnose and monitor bacterial infections and related nociceptive pain linked to tissue acidity. The MRS system includes an interfacing DDD-MRS signal processor that captures output signals to create a post-processed spectrum, highlighting specific chemical biomarkers. Moreover, a diagnostic processor derives diagnostic values for each disc while normalizing ratios of spectral regions associated with chemicals relevant to degenerative tissue pathology.

Career Highlights

Lotz has had a noteworthy career, with pivotal roles at the University of California and Nocimed, Inc. His work has significantly impacted the understanding and diagnosis of pain, particularly in conditions that involve degenerative changes in tissue. Through his inventions, he has paved the way for improved diagnostic methodologies in modern medicine.

Collaborations

Throughout his career, Jeffrey has collaborated with esteemed colleagues such as David S. Bradford and Chris J. Diederich. These partnerships have facilitated innovative research and development in the field of magnetic resonance spectroscopy, further enhancing its applications in medical diagnostics.

Conclusion

Jeffrey Charles Lotz continues to be a leading figure in his field, with a strong focus on leveraging technology to enhance diagnostic processes. His innovative patents and collaborations exemplify his commitment to advancing medical science, making significant strides toward improved patient care and diagnostic accuracy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…